BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 16339680)

  • 21. Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency.
    Chou R; DeLoughery TG
    Am J Hematol; 2001 Jul; 67(3):197-9. PubMed ID: 11391719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Portal vein thrombosis after splenectomy in pediatric hematologic disease: risk factors, clinical features, and outcome.
    Soyer T; Ciftci AO; Tanyel FC; Senocak ME; Büyükpamukçu N
    J Pediatr Surg; 2006 Nov; 41(11):1899-902. PubMed ID: 17101367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalassemia intermedia: revisited.
    Taher A; Isma'eel H; Cappellini MD
    Blood Cells Mol Dis; 2006; 37(1):12-20. PubMed ID: 16737833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Splenectomy for children with thalassemia.
    Al-Salem AH; Nasserulla Z
    Int Surg; 2002; 87(4):269-73. PubMed ID: 12575813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombosis in thalassemia: why are we so concerned?
    Musallam KM; Taher AT
    Hemoglobin; 2011; 35(5-6):503-10. PubMed ID: 21910599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood coagulation and platelet profiles in persistent post-splenectomy thrombocytosis. The relationship to thromboembolism.
    Visudhiphan S; Ketsa-Ard K; Piankijagum A; Tumliang S
    Biomed Pharmacother; 1985; 39(6):264-71. PubMed ID: 4084660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemostatic alterations in splenectomized and non-splenectomized patients with beta-thalassemia/hemoglobin E disease.
    Tripatara A; Jetsrisuparb A; Teeratakulpisarn J; Kuaha K
    Thromb Res; 2007; 120(6):805-10. PubMed ID: 17382994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to hydroxyurea therapy in beta-thalassemia.
    Koren A; Levin C; Dgany O; Kransnov T; Elhasid R; Zalman L; Palmor H; Tamary H
    Am J Hematol; 2008 May; 83(5):366-70. PubMed ID: 18181203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypercoagulability in non-transfusion-dependent thalassemia.
    Cappellini MD; Musallam KM; Poggiali E; Taher AT
    Blood Rev; 2012 Apr; 26 Suppl 1():S20-3. PubMed ID: 22631037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of blood coagulation and platelet profiles in relation to pulmonary thrombosis in beta-thalassemia/Hb E.
    Visudhiphan S; Ketsa-Ard K; Tumliang S; Piankijagum A
    Southeast Asian J Trop Med Public Health; 1994 Sep; 25(3):449-56. PubMed ID: 7777905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Splenectomy and infection in homozygous beta-thalassemia. The uselessness of penicillin prophylaxis].
    Arigliani R; Molinari AC; Favareto F; Traverso T; Melevendi C; Boeri E; Mori PG
    Pediatr Med Chir; 1987; 9(3):281-2. PubMed ID: 3118339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral thrombosis in patients with β-thalassemia: a systematic review.
    Haghpanah S; Karimi M
    Blood Coagul Fibrinolysis; 2012 Apr; 23(3):212-7. PubMed ID: 22322139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins.
    Stamou KM; Toutouzas KG; Kekis PB; Nakos S; Gafou A; Manouras A; Krespis E; Katsaragakis S; Bramis J
    Arch Surg; 2006 Jul; 141(7):663-9. PubMed ID: 16847237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thromboembolic complications in an asplenic HbE-beta-thalassaemia patient.
    van Teunenbroek A; Wijburg FA; ten Cate JW; van den Berg W; Weening RS
    Neth J Med; 1989 Oct; 35(3-4):123-7. PubMed ID: 2601789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thalassemia intermedia: 36 cases].
    Hafsia R; Ben Salah N; Hafhouf E; Belakhal F; Gouider E; El Borji W; Meddeb B
    Tunis Med; 2010 Feb; 88(2):102-4. PubMed ID: 20415168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased circulating platelet aggregates in thalassaemia.
    Winichagoon P; Fucharoen S; Wasi P
    Southeast Asian J Trop Med Public Health; 1981 Dec; 12(4):556-60. PubMed ID: 7344105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective clinical remarks in thalassemia intermedia.
    Dore F; Cianciulli P; Oggiano L; Pardini S; Bonfigli S; Ganau A; Piga G; Trua G; Papa G; Longinotti M
    Haematologica; 1990; 75 Suppl 5():9-25. PubMed ID: 2086387
    [No Abstract]   [Full Text] [Related]  

  • 38. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty.
    Chotanaphuti T; Ongnamthip P; Silpipat S; Foojareonyos T; Roschan S; Reumthantong A
    J Med Assoc Thai; 2007 Jul; 90(7):1342-7. PubMed ID: 17710975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D-dimer and portal vein status in splenectomized Egyptian β-thalassemia major patients: a prospective single-thalassemia center experience.
    Elalfy MS; Andrawes NG; Sadek AM; Hussein O; Abdou A
    Pediatr Hematol Oncol; 2012 Apr; 29(3):247-53. PubMed ID: 22475301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indications and results for splenectomy for beta thalassemia in two hundred and twenty-one pediatric patients.
    Pinna AD; Argiolu F; Marongiu L; Pinna DC
    Surg Gynecol Obstet; 1988 Aug; 167(2):109-13. PubMed ID: 3400027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.